Abstract:Background: Hepatitis Be antigen (HBeAg) precursor proteins, which share an identical encoding PreC/C open reading frame (PreC/C-ORF) of hepatitis B virus (HBV) core, can inhibit viral replication in vitro. The apolipoprotein B mRNA (messenger ribonucleic acid) editing enzyme catalytic polypeptide 3A (APOBEC3A) can inhibit HBV replication by interacting with the HBV core protein. The aim of the study was to explore whether the HBeAg precursor proteins can regulate HBV replication by interacting with APOBEC3A.Methods: Plasmids harboring the coding sequence of HBeAg precursor proteins (P25 and P22) and APOBEC3A were individu-ally or co-transfected into human hepatoma and embryonic kidney cells. P25, P22, and APOBEC3A expressions were quantified by Western blotting. The co-localization and interaction of P25, P22, and APOBEC3A were determined by confocal microscopy and co-immunoprecipitation (Co-IP). We constructed serial precursor proteins of HBeAg deletion mutants for further Co-IP analysis. Enzyme-linked immunosorbent assay (ELISA) was employed to evaluate the levels of HBeAg and HBsAg. HBV repli-cation intermediates from the transfected cells were detected by Southern blotting.Results: P25, P22, and APOBEC3A proteins were successfully expressed in transfected cells, and P25 or P22 protein co-localization with APOBEC3A protein in the cytoplass. Co-IP with APOBEC3A was mediated by the central region of the HBeAg precursor (amino acids 107-178). The levels of HBsAg were significantly lower in cells co-transfected with HBV e-, P22/P25, and APOBEC3A, than in cells co-transfected with HBV e-, APOBEC3A, or in cells co-transfected with HBV e-, P22/P25. The levels of HBeAg were lower in cells co-transfected with HBV e-, P22/P25, and APOBEC3A, than in cells co-transfected with HBV e-, P22/P25. Compare with cells transfected with HBV e-, APOBEC3A, or in cells co-transfected with HBV e-, P25/P22, HBV replication intermediates were lower in the cells co-transfected with HBV e-, P25, APOBEC3A, and significantly lower in the cells with HBV e-, P22, APOBEC3A.Conclusions: HBV replication can be inhibited by the interaction of P25/P22 with APOBEC3A protein in the cytoplasm.

Host Apolipoprotein B Messenger RNA-editing Enzyme Catalytic Polypeptide-Like 3G is an Innate Defensive Factor and Drug Target Against Hepatitis C Virus

Host APOBEC3G Protein Inhibits HCV Replication Through Direct Binding at NS3.

USP49 Potently Stabilizes APOBEC3G Protein by Removing Ubiquitin and Inhibits HIV-1 Replication

Inhibition of Hepatitis B Virus Replication by APOBEC3G in Vitro and in Vivo.

N-terminal and C-terminal Cytosine Deaminase Domain of APOBEC3G Inhibit Hepatitis B Virus Replication

APOBEC3G Directly Binds Hepatitis B Virus Core Protein in Cell and Cell Free Systems

Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression.

The Cellular Antiviral Protein APOBEC3G Interacts with HIV-1 Reverse Transcriptase and Inhibits Its Function During Viral Replication

[Inhibitory Effect of a HBV Vector Plasmid Expressing A3C on HBV Replication].

Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G

Reduced Apobec3h Variant Anti-Viral Activities Are Associated With Altered Rna Binding Activities

Small Molecular Compounds That Inhibit Hepatitis C Virus Replication Through Destabilizing Heat Shock Cognate 70 Messenger RNA.

Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation

Identification of an Hiv-1 Replication Inhibitor Which Rescues Host Restriction Factor Apobec3g in Vif-Apobec3g Complex

Hepatitis C Virus Co-Opts Ras-Gtpase-Activating Protein-Binding Protein 1 for Its Genome Replication

Functional analysis of the two cytidine deaminase domains in APOBEC3G.

Interferon-Stimulated SAMHD1 Restricts Hepatitis C Virus Replication

Inhibitors of Endoplasmic Reticulum Α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release

A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction

HBeAg Precursor Proteins Interact with APOBEC3A and Inhibit HBV Replication

Stably Silencing Of Cd81 Expression By Small Interfering Rnas Targeting 3 '-Ntr Inhibits Hcv Infection